QS Investors’s STAAR Surgical STAA Stock Holding History

QS Investors’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$992K	Sell	6,500 -6,000	-48%	-$790K	0.01%	496
2021 Q1	$1.32M	Sell	12,500 -200	-2%	-$20K	0.02%	451
2020 Q4	$1.01M	Hold	12,700	–	–	0.01%	504
2020 Q3	$719K	Sell	12,700 -66,250	-84%	-$3.57M	0.01%	558
2020 Q2	$4.86M	Hold	78,950	–	–	0.07%	222
2020 Q1	$2.55M	Hold	78,950	–	–	0.04%	339
2019 Q4	$2.75M	Sell	78,950 -900	-1%	-$29.7K	0.03%	478
2019 Q3	$2.06M	Hold	79,850	–	–	0.02%	559
2019 Q2	$2.35M	Sell	79,850 -1,500	-2%	-$43.3K	0.03%	526
2019 Q1	$2.78M	Buy	81,350 +18,800	+30%	+$665K	0.03%	470
2018 Q4	$2M	Buy	+62,550	New	+$2.44M	0.03%	547

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

QS Investors's STAA Position: Q2 2021 in Review

QS Investors reduced its STAAR Surgical (STAA) stake by 48% in Q2 2021, selling an estimated $790K and leaving 6,500 shares worth $992K. The position accounts for 0.01% of the portfolio, ranked #496.

QS Investors first reported a position in STAA in Q4 2018 and has held it in 11 quarters since. The position peaked at $4.86M in Q2 2020. 283 funds tracked by Wall St. Rank hold STAA as of Q2 2021.

QS Investors held 6,500 shares of STAAR Surgical worth $992K as of Q2 2021.
QS Investors sold 6,000 STAAR Surgical shares in Q2 2021, an estimated $790K.
STAAR Surgical made up 0.01% of QS Investors's portfolio in Q2 2021, its #496 holding.
QS Investors first reported a position in STAAR Surgical in Q4 2018 and has held it in 11 quarters since.
QS Investors's STAAR Surgical position peaked at $4.86M in Q2 2020.
283 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.